The global Asset Performance Management (APM) market is projected to grow at a compound annual growth rate (CAGR) of 10.8%, ...

The FDA-approved imaging agent for detecting coronary artery disease gained Medicare and Medicaid coverage starting April 1.

GE HealthCare is also using ACC 2025 to highlight new AI-powered innovations for cardiac care: The latest version of CASE (Cardiac Assessment System for Stress Testing), powered by the company’s ...

We recently published a list of Was Jim Cramer Right About These 13 Stocks? In this article, we are going to take a look at ...

GE HealthCare Technologies introduced Genesis Solutions, a new portfolio of cloud enterprise imaging SaaS solutions, aimed at enhancing efficiency and precision in healthcare. This development ...

LAS VEGAS--(BUSINESS WIRE)--GE HealthCare (Nasdaq: GEHC) today announced its new Genesis solutions, a portfolio of cloud enterprise imaging software-as-a-service (SaaS) solutions. Four features ...

If you want to know who really controls GE HealthCare Technologies Inc. (NASDAQ:GEHC), then you'll have to look at the makeup of its share registry. And the group that holds the biggest piece of ...

GE HealthCare Technologies Inc. GEHC recently announced the U.S. launch of Flyrcado (flurpiridaz F 18) injection at the ongoing American College of Cardiology (ACC) Annual Scientific Session & Expo.

GE Healthcare and Nvidia have launched a collaboration to develop AI-powered autonomous X-ray and ultrasound technologies, with an aim to address growing radiology staff shortages and improve ...

We recently published a list of Top 9 AI Ratings and News Updates on Wall Street’s Radar. In this article, we are going to ...

River Road Asset Management, an investment management company released its “River Road Large Cap Value Select Fund” Q4 2024 investor letter. A copy of the letter can be downloaded here.